Drug Type Small molecule drug |
Synonyms Budiodarone (USAN/INN), Budiodarone Tartrate |
Mechanism Potassium channel blockers, Sodium channels blockers, VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H31I2NO5 |
InChIKeyZXOSVKYCXLTVGS-KRWDZBQOSA-N |
CAS Registry335148-45-3 |
Start Date20 Sep 2007 |
Sponsor / Collaborator |
Start Date01 Jul 2006 |
Sponsor / Collaborator |
Start Date10 Mar 2005 |
Sponsor / Collaborator- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09590 | Budiodarone | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tachycardia, Ventricular | Phase 2 | - | - | |
Tachycardia, Ventricular | Phase 2 | - | - | |
Atrial Fibrillation | Phase 1 | CA | 01 Jul 2006 | |
Atrial Fibrillation | Phase 1 | US | 01 Jul 2006 | |
Tachycardia, Ventricular | Preclinical | US | - |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |